Cxcr4 agonist treatment of hematopoietic cells

Details for Australian Patent Application No. 2001252081 (hide)

Owner The University of British Columbia Chemokine Therapeutics Corporation

Inventors Clark-Lewis, Ian; Eaves, Connie J.; Salari, Hassan; Merzouk, Ahmed; Arab, Lakhdar; Tudan, Christopher R.; Saxena, Geeta; Cashman, Johanne

Agent Spruson & Ferguson

Pub. Number AU-B-2001252081

PCT Pub. Number WO01/76615

Priority 2305036 12.04.00 CA; 2335109 23.02.01 CA; 60232425 14.09.00 US

Filing date 12 April 2001

Wipo publication date 23 October 2001

Acceptance publication date 23 December 2004

International Classifications

A61K 038/00 Medicinal preparations containing peptides

Event Publications

23 December 2004 Application Accepted

  Published as AU-B-2001252081

21 April 2005 Standard Patent Sealed

1 April 2010 Alteration of Name

  The name of the patentee has been altered to The University Of British Columbia; British Canadian Biosciences Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001252082-Two way cable system with noise-free return path

2001252080-Seal assembly for limiting the movement of a seal within a seal housing